Alnylam Pharmaceuticals (ALNY)'s 30-day implied volatility (IV30) was 63.0% at the close on October 23, 2026, up from 62.0% the day before, against a 52-week range of 35.6% to 63.2%. Its 20-day historical volatility was 43.8%.
Data as of October 23, 2026.